INVESTABOT
Equity Research
XNYS · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
McKesson (MCK) had 1 Form 144 pre-sale notice filed on 2026-07-07. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
McKesson (MCK) had 1 Form 144 pre-sale notice filed on 2026-06-02. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
McKesson (MCK) had 1 Form 144 pre-sale notice filed on 2026-06-17. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
McKesson (MCK) had 1 Form 144 pre-sale notice filed on 2026-06-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
McKesson (MCK) had 1 Form 144 pre-sale notice filed on 2026-06-09. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
McKesson (MCK) had 1 Form 144 pre-sale notice filed on 2026-06-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
McKesson (MCK) had 2 Form 144 pre-sale notices filed on 2026-05-26. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing ref…
TL;DR: McKesson reported Q4 revenue of $96.3 billion (up 6% from $90.8 billion a year ago) and earnings per diluted share of $13.71, a 37% jump from $10.01 in the prior-year quarter.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 8/10/2026 | Lerman Bradley E | — | SELL | -301 | $892 | $268,590 |
| 8/7/2026 | Srinivasan Ramesh (NMN) | EVP and Chief Strategy Officer | GRANT | 368 | — | — |
| 7/22/2026 | Hinton James H. | — | GRANT | 277 | — | — |
| 7/22/2026 | Doughtie Lynne M | — | GRANT | 277 | — | — |
| 7/22/2026 | Wilson-Thompson Kathleen | — | GRANT | 277 | $814 | $225,489 |
| 7/22/2026 | Dunbar Webster Roy | — | GRANT | 277 | — | — |
| 7/22/2026 | Caruso Dominic J | — | GRANT | 277 | $814 | $225,489 |
| 7/22/2026 | Gerberding Julie L. | — | GRANT | 277 | — | — |
| 7/22/2026 | Lerman Bradley E | — | GRANT | 277 | — | — |
| 7/22/2026 | Martinez Maria | — | GRANT | 277 | $814 | $225,489 |
| 7/22/2026 | OZAN KEVIN M | — | GRANT | 277 | — | — |
| 7/22/2026 | Dunsire Deborah | — | GRANT | 277 | — | — |
| 7/7/2026 | TYLER BRIAN S. | Chief Executive Officer | SELL | -8,463 | $794 | $6,715,898 |
| 6/17/2026 | TYLER BRIAN S. | Chief Executive Officer | SELL | -8,463 | $775 | $6,559,925 |
| 6/9/2026 | TYLER BRIAN S. | Chief Executive Officer | SELL | -4,929 | $763 | $3,760,827 |
| 6/5/2026 | Rutledge Napoleon B JR | SVP, Controller & CAO | SELL | -133 | $764 | $101,612 |
| 6/2/2026 | Rodgers Thomas L | EVP, Chief Strategy & BDO | SELL | -699 | $735 | $513,954 |
| 6/1/2026 | Smith LeAnn B | EVP & Chief HR Officer | SELL | -1,810 | $736 | $1,331,255 |
| 6/1/2026 | Rodgers Thomas L | EVP, Chief Strategy & BDO | SELL | -123 | $736 | $90,467 |
| 5/29/2026 | Cheung Kenny K | EVP & CFO | GRANT | 8,082 | — | — |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 8/10/2026 | Lerman Bradley E | — | 301 | SEC |
| 8/3/2026 | Vitalone Britt J. | — | 7,925 | SEC |
| 7/7/2026 | TYLER BRIAN S. | — | 8,463 | SEC |
| 6/17/2026 | TYLER BRIAN S. | — | 8,463 | SEC |
| 6/9/2026 | TYLER BRIAN S. | — | 4,929 | SEC |
| 6/2/2026 | Rodgers Thomas L | — | 699 | SEC |
| 6/1/2026 | Rodgers Thomas L | — | 123 | SEC |
| 6/1/2026 | Smith LeAnn B | — | 1,810 | SEC |
| 5/26/2026 | Rodgers Thomas L | — | 2,388 | SEC |
| 5/26/2026 | Lau Michele | — | 3,550 | SEC |